163 related articles for article (PubMed ID: 24548537)
1. Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept.
Tichy M; Hercogova J
Dermatol Ther; 2014; 27(4):211-4. PubMed ID: 24548537
[TBL] [Abstract][Full Text] [Related]
2. Etanercept therapy for psoriasis in a patient with numerous comorbidities.
De Simone C; Carbone A; Caldarola G
Am J Clin Dermatol; 2010; 11 Suppl 1():49-50. PubMed ID: 20586510
[TBL] [Abstract][Full Text] [Related]
3. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.
Ko JM; Gottlieb AB; Kerbleski JF
J Dermatolog Treat; 2009; 20(2):100-8. PubMed ID: 18923992
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.
Fouache D; Goëb V; Massy-Guillemant N; Avenel G; Bacquet-Deschryver H; Kozyreff-Meurice M; Ménard JF; Muraine M; Savoye G; Le Loët X; Tharasse C; Vittecoq O
Rheumatology (Oxford); 2009 Jul; 48(7):761-4. PubMed ID: 19395543
[TBL] [Abstract][Full Text] [Related]
5. [Onset of Crohn's disease induced by etanercept therapy: a case report].
Mrabet D; Selmi A; Filali A; Sahli H; Sellami S
Rev Med Liege; 2012 Dec; 67(12):619-22. PubMed ID: 23342871
[TBL] [Abstract][Full Text] [Related]
6. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
Famenini S; Wu JJ
J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
Landells I; Paller AS; Pariser D; Kricorian G; Foehl J; Molta C; Freundlich B
Eur J Dermatol; 2010; 20(3):323-8. PubMed ID: 20185386
[TBL] [Abstract][Full Text] [Related]
8. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).
Yazisiz V; Avci AB; Erbasan F; Yildirim B; Terzioğlu E
Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265
[TBL] [Abstract][Full Text] [Related]
9. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.
Lee ES; Heller MM; Kamangar F; Park KK; Koo JY
J Drugs Dermatol; 2012 Mar; 11(3):413-4. PubMed ID: 22395596
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
11. Nodular fasciitis: a possible side effect of etanercept?
Vine K; Dacko A; Weinberg JM
Cutis; 2013 Oct; 92(4):199-202. PubMed ID: 24195093
[TBL] [Abstract][Full Text] [Related]
12. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
13. Etanercept treatment for children and adolescents with plaque psoriasis.
Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A;
N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
15. New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
Song IH; Appel H; Haibel H; Loddenkemper C; Braun J; Sieper J; Rudwaleit M
J Rheumatol; 2008 Mar; 35(3):532-6. PubMed ID: 18203308
[TBL] [Abstract][Full Text] [Related]
16. The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
Young MS; Horn EJ; Cather JC
Expert Rev Clin Immunol; 2011 Jan; 7(1):9-13. PubMed ID: 21162644
[TBL] [Abstract][Full Text] [Related]
17. Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report.
Skroza N; Proietti I; Bernardini N; La Viola G; Nicolucci F; Tolino E; Zuber S; Potenza C
Cutis; 2012 Sep; 90(3):120-2. PubMed ID: 23094309
[TBL] [Abstract][Full Text] [Related]
18. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
[TBL] [Abstract][Full Text] [Related]
19. Etanercept for psoriasis: two case reports.
Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
[TBL] [Abstract][Full Text] [Related]
20. Onset of lichen planus during treatment with etanercept.
Musumeci ML; Lacarrubba F; Micali G
Am J Clin Dermatol; 2010; 11 Suppl 1():55-6. PubMed ID: 20586513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
